Video

Disparities Exist in Young Patients with Colorectal and Gastric Cancers

Author(s):

The incidence of colorectal and gastric cancers has risen for younger patients, and many of them share ethnic and socioeconomic disparities as well.

As the incidence of colorectal and gastric cancers in younger patients has risen in recent years, researchers have found this population to have other factors in common — most notably ethnic and socioeconomic disparities.

Dr. Amir Khan and his team analyzed data from the California Cancer Registry spanning from 2000 to 2012 to find information on the different age groups of patients who have received colorectal and gastric cancer diagnoses. They found an increased incidence of the disease in patients aged 18-40, and that these younger patients were more likely to be uninsured, of low socioeconomic status or of Hispanic descent.

During the annual American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Khan, a fellow in surgical oncology at City of Hope National Medical Center in Duarte, California, met with CURE® to discuss the results of his team’s study and the data their findings have uncovered.

Transcription:

We found that the youngest age group, 18-40, (that there were) ethnic and socioeconomic disparities. Hispanic ethnicity was much more common in the younger population. In the group that was aged 65-90 maybe about 20% of gastric cancers were among Hispanics as opposed to the 18-40 group (where) 50% of patients were Hispanic.

We also found that younger patients were more likely to be uninsured and of low socioeconomic status. We found that these patients may present with later stage disease — stage 3 and stage 4 — and they had certain histopathologic features that suggested a more aggressive disease process. They had more poorly differentiated tumors, (and) in terms of gastric cancer they had diffuse type pathology and poorly differentiated tumors as well.

Related Videos
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Michael Bogenschutz
Related Content